Literature DB >> 21195149

Furazolidone induced oxidative DNA damage via up-regulating ROS that caused cell cycle arrest in human hepatoma G2 cells.

Xi Jin1, Shusheng Tang, Qian Chen, Jiajie Zou, Ting Zhang, Fengying Liu, Shen Zhang, Chundi Sun, Xilong Xiao.   

Abstract

Furazolidone (FZD) is an antimicrobial agent that has been shown to have mutagenic, genotoxic and potentially carcinogenic properties when tested in a variety of systems in vitro and in vivo. In this study, we investigated FZD's DNA damaging effect in human hepatoma cells aiming at further defining the molecular mechanism of FZD's cytotoxicity. Addition of FZD resulted in cell growth suppression and cell cycle arrest in S phase accompanied by remarkable DNA strand breaks with increased levels of intracellular reactive oxygen species (ROS) and 8-hydroxydeoxyguanosine. Activities of antioxidases were down-regulated following FZD treatment and antioxidant agent catalase and superoxide dismutase ameliorated FZD's DNA damaging effects. Moreover, FZD caused much more extensive damage to mitochondrial DNA (mtDNA) than to nuclear DNA for which the decrease in mtDNA content correlated with FZD usage in a dose-dependent manner. However, there was no evidence of FZD induced mtDNA mutation in the mitochondrial DNA displacement loop. These results demonstrate that FZD up-regulates the production of intracellular ROS to cause oxidative DNA damage with mtDNA being the most vulnerable targets. Oxidative stress and the injury of mtDNA could be early indicators of FZD-induced cytotoxicity, with the resulting abnormal progression of the cell cycle.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21195149     DOI: 10.1016/j.toxlet.2010.12.021

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  11 in total

1.  Alterations of antioxidant indexes and inflammatory cytokine expression aggravated hepatocellular apoptosis through mitochondrial and death receptor-dependent pathways in Gallus gallus exposed to arsenic and copper.

Authors:  Juanjuan Liu; Hongjing Zhao; Yu Wang; Yizhi Shao; Jinglun Li; Mingwei Xing
Journal:  Environ Sci Pollut Res Int       Date:  2018-03-22       Impact factor: 4.223

2.  Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation.

Authors:  Lu Wang; Hongtao Li; Shengpeng Wang; Rong Liu; Zhisheng Wu; Chunming Wang; Yitao Wang; Meiwan Chen
Journal:  AAPS PharmSciTech       Date:  2014-04-03       Impact factor: 3.246

Review 3.  Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis.

Authors:  Angelo Zullo; Enzo Ierardi; Cesare Hassan; Vincenzo De Francesco
Journal:  Saudi J Gastroenterol       Date:  2012 Jan-Feb       Impact factor: 2.485

4.  A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia.

Authors:  Xueqing Jiang; Lin Sun; Jihui Julia Qiu; Xiujing Sun; Sen Li; Xiyin Wang; Chi Wai Eric So; Shuo Dong
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

5.  GADD45a Regulates Olaquindox-Induced DNA Damage and S-Phase Arrest in Human Hepatoma G2 Cells via JNK/p38 Pathways.

Authors:  Daowen Li; Chongshan Dai; Xiayun Yang; Bin Li; Xilong Xiao; Shusheng Tang
Journal:  Molecules       Date:  2017-01-13       Impact factor: 4.411

6.  Curcumin Ameliorates Furazolidone-Induced DNA Damage and Apoptosis in Human Hepatocyte L02 Cells by Inhibiting ROS Production and Mitochondrial Pathway.

Authors:  Chongshan Dai; Daowen Li; Lijing Gong; Xilong Xiao; Shusheng Tang
Journal:  Molecules       Date:  2016-08-22       Impact factor: 4.411

7.  Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance.

Authors:  Muhammad Miftahussurur; Langgeng Agung Waskito; Ari Fahrial Syam; Iswan Abbas Nusi; Gontar Siregar; Marselino Richardo; Achmad Fuad Bakry; Yudith Annisa Ayu Rezkitha; I Dewa Nyoman Wibawa; Yoshio Yamaoka
Journal:  Infect Drug Resist       Date:  2019-01-31       Impact factor: 4.003

8.  Levofloxacin and furazolidone induced toxic epidermal necrosis.

Authors:  Sushil Kumar Varma; Shanta Sutradhar; Arup Kumar Misra
Journal:  Indian J Pharmacol       Date:  2013 Nov-Dec       Impact factor: 1.200

9.  Physiological oxygen tension reduces hepatocyte dedifferentiation in in vitro culture.

Authors:  Ren Guo; Xinxiu Xu; Yuting Lu; Xin Xie
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

10.  Outcomes of furazolidone- and amoxicillin-based quadruple therapy for Helicobacter pylori infection and predictors of failed eradication.

Authors:  Ya-Wen Zhang; Wei-Ling Hu; Yuan Cai; Wen-Fang Zheng; Qin Du; John J Kim; John Y Kao; Ning Dai; Jian-Min Si
Journal:  World J Gastroenterol       Date:  2018-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.